ALFREDO
RODRÍGUEZ ANTIGÜEDAD ZARRANTZ
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublikationen in Zusammenarbeit mit Forschern von Ikerbasque, Fundación Vasca para la Ciencia (6)
2023
-
Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats
Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316
2015
-
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512
-
Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154
2014
-
Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology
PLoS ONE, Vol. 9, Núm. 12
2013
-
TNFRSF1A polymorphisms rs1800693 and rs4l49584 in patients with multiple sclerosis
Neurology, Vol. 80, Núm. 22, pp. 2010-2016
2012
-
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990